• Nationalestraat 155

    2000 Antwerpen

    Belgium

Find us here

Organization profile

Organisation profile

Introduction

In the Unit of Molecular Parasitology, the focus lays on Leishmania, with a particular attention on drug-resistance and associated phenotypes (drug resistant parasites are also more virulent). Genomics and metabolomics are running since 4 years and we now enter the phase of functional testing of the importance of gene dosage in the survival skills of the parasite; integration in a true systems biology approach (through the addition of transcriptomic and proteomic layers) is considered. We also aim to develop methods allowing direct whole genome sequencing in (sub)clinical samples as well as single cell genomics.

Jean-Claude Dujardin is the head of the Unit of Molecular Parasitology since 2002.

Main activities

  • Drug resistance in leishmaniasis: mechanisms, link with survival skills, in vitro and in vivo phenotyping, experimental validation, surveillance tools, interacting closely with ‘clinomics’ line; our expertise in drug resistance is also used to support R&D for new antileishmania drugs
  • ‘Clinomic’ diversity in leishmania: genomic, transcriptomic, metabolomic exploitation of parasite collections linked to well-documented cohorts of patients (understanding of clinical and in vitro/vivo phenotypic diversity, parasite evolution)
  • Molecular epidemiology of leishmaniasis: (i) further dissemination of standardized and QA-typing tests and (ii) application of molecular tools for characterization of transmission patterns (with a special interest for asymptomatic infections)

Fingerprint

Dive into the research topics where Molecular Parasitology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • A community resource for paired genomic and metabolomic data mining

    Schorn, M. A., Verhoeven, S., Ridder, L., Huber, F., Acharya, D. D., Aksenov, A. A., Aleti, G., Moghaddam, J. A., Aron, A. T., Aziz, S., Bauermeister, A., Bauman, K. D., Baunach, M., Beemelmanns, C., Beman, J. M., Berlanga-Clavero, M. V., Blacutt, A. A., Bode, H. B., Boullie, A., Brejnrod, A. & 90 others, Bugni, T. S., Calteau, A., Cao, L., Carrión, V. J., Castelo-Branco, R., Chanana, S., Chase, A. B., Chevrette, M. G., Costa-Lotufo, L. V., Crawford, J. M., Currie, C. R., Cuypers, B., Dang, T., de Rond, T., Demko, A. M., Dittmann, E., Du, C., Drozd, C., Dujardin, J-C., Dutton, R. J., Edlund, A., Fewer, D. P., Garg, N., Gauglitz, J. M., Gentry, E. C., Gerwick, L., Glukhov, E., Gross, H., Gugger, M., Guillén Matus, D. G., Helfrich, E. J. N., Hempel, B-F., Hur, J-S., Iorio, M., Jensen, P. R., Kang, K. B., Kaysser, L., Kelleher, N. L., Kim, C. S., Kim, K. H., Koester, I., König, G. M., Leao, T., Lee, S. R., Lee, Y-Y., Li, X., Little, J. C., Maloney, K. N., Männle, D., Martin H, C., McAvoy, A. C., Metcalf, W. W., Mohimani, H., Molina-Santiago, C., Moore, B. S., Mullowney, M. W., Muskat, M., Nothias, L-F., O'Neill, E. C., Parkinson, E. I., Petras, D., Piel, J., Pierce, E. C., Pires, K., Reher, R., Romero, D., Roper, M. C., Rust, M., Saad, H., Saenz, C., Sanchez, L. M., Sørensen, S. J., Sosio, M., Süssmuth, R. D., Sweeney, D., Tahlan, K., Thomson, R. J., Tobias, N. J., Trindade-Silva, A. E., van Wezel, G. P., Wang, M., Weldon, K. C., Zhang, F., Ziemert, N., Duncan, K. R., Crüsemann, M., Rogers, S., Dorrestein, P. C., Medema, M. H. & van der Hooft, J. J. J., 2021, In : Nature Chemical Biology. 17, 4, p. 363-368 6 p.

    Research output: Contribution to journalComment/debate

  • Assessing L. donovani skin parasite load: a proof of concept study of a microbiopsy device in an Indian setting

    Cloots, K., Singh, O. P., Singh, A. K., Van der Auwera, G., Kumar, P., Gedda, M. R., Rai, T. K., Hasker, E., Sundar, S. & Boelaert, M., 2021, In : Frontiers in Cellular and Infection Microbiology. 11, 9 p., 645121.

    Research output: Contribution to journalA1: Web of Science-article

    Open Access
    File
    1 Downloads (Pure)
  • Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer

    Boullosa, L. F., Van Loenhout, J., Flieswasser, T., De Waele, J., Hermans, C., Lambrechts, H., Cuypers, B., Laukens, K., Bartholomeus, E., Siozopoulou, V., De Vos, W. H., Peeters, M., Smits, E. L. J. & Deben, C., 2021, In : Redox Biology. 42, 17 p., 101949.

    Research output: Contribution to journalA1: Web of Science-article